PMC:7102591 / 20576-20836 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"599","span":{"begin":102,"end":105},"obj":"Gene"},{"id":"603","span":{"begin":54,"end":58},"obj":"Disease"},{"id":"604","span":{"begin":77,"end":101},"obj":"Disease"},{"id":"605","span":{"begin":186,"end":201},"obj":"Disease"}],"attributes":[{"id":"A599","pred":"tao:has_database_id","subj":"599","obj":"Gene:7124"},{"id":"A603","pred":"tao:has_database_id","subj":"603","obj":"MESH:D012128"},{"id":"A604","pred":"tao:has_database_id","subj":"604","obj":"MESH:D060085"},{"id":"A605","pred":"tao:has_database_id","subj":"605","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T75","span":{"begin":17,"end":25},"obj":"Body_part"},{"id":"T76","span":{"begin":162,"end":166},"obj":"Body_part"}],"attributes":[{"id":"A75","pred":"fma_id","subj":"T75","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T233","span":{"begin":54,"end":58},"obj":"Disease"},{"id":"T234","span":{"begin":91,"end":101},"obj":"Disease"},{"id":"T235","span":{"begin":186,"end":201},"obj":"Disease"},{"id":"T236","span":{"begin":192,"end":201},"obj":"Disease"}],"attributes":[{"id":"A233","pred":"mondo_id","subj":"T233","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A234","pred":"mondo_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A235","pred":"mondo_id","subj":"T235","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A236","pred":"mondo_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T142","span":{"begin":162,"end":166},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T161","span":{"begin":106,"end":116},"obj":"Chemical"},{"id":"T162","span":{"begin":207,"end":213},"obj":"Chemical"}],"attributes":[{"id":"A161","pred":"chebi_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A162","pred":"chebi_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/CHEBI_35475"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T36","span":{"begin":135,"end":152},"obj":"http://purl.obolibrary.org/obo/GO_0046718"},{"id":"T37","span":{"begin":186,"end":201},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T38","span":{"begin":232,"end":249},"obj":"http://purl.obolibrary.org/obo/GO_0046718"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}

{"project":"LitCovid-sentences","denotations":[{"id":"T111","span":{"begin":4,"end":101},"obj":"Sentence"},{"id":"T112","span":{"begin":102,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T69","span":{"begin":17,"end":31},"obj":"Phenotype"}],"attributes":[{"id":"A69","pred":"hp_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"nse\nTreatment of cytokine storm manifestations during ARDS Increased risk of secondary HZV infections\nTNF-inhibitors Interference with viral penetration into the cell Slight increase in viral infection risk\nNSAIDs – Facilitation of viral penetration by overexp"}